Ballantyne Jane C, LaForge Steven K
Division of Pain Medicine, Massachusetts General Hospital Pain Center, Boston, MA 02114, USA Harvard Medical School, Boston Massachusetts, USA Finnish Genome Center, The University of Helsinki, Helsinki, Finland.
Pain. 2007 Jun;129(3):235-255. doi: 10.1016/j.pain.2007.03.028. Epub 2007 May 4.
Throughout the long history of opioid drug use by humans, it has been known that opioids are powerful analgesics, but they can cause addiction. It has also been observed, and is now substantiated by multiple reports and studies, that during opioid treatment of severe and short-term pain, addiction arises only rarely. However, when opioids are extended to patients with chronic pain, and therapeutic opioid use is not confined to patients with severe and short-lived pain, compulsive opioid seeking and addiction arising directly from opioid treatment of pain become more visible. Although the epidemiological evidence base currently available is rudimentary, it appears that problematic opioid use arises in some fraction of opioid-treated chronic pain patients, and that problematic behaviors and addiction are problems that need to be addressed. Since the potentially devastating effects of addiction can substantially offset the benefits of opioid pain relief, it seems timely to reexamine addiction mechanisms and their relevance to the practice of long-term opioid treatment for pain. This article reviews the neurobiological and genetic basis of addiction, its terminology and diagnosis, the evidence on addiction rates during opioid treatment of chronic pain and the implications of biological mechanisms in formulating rational opioid treatment regimes.
在人类使用阿片类药物的漫长历史中,人们一直都知道阿片类药物是强效镇痛药,但会导致成瘾。人们也观察到,现在多项报告和研究也证实,在阿片类药物用于治疗严重短期疼痛时,成瘾情况很少出现。然而,当阿片类药物用于慢性疼痛患者,且阿片类药物治疗并不局限于严重短期疼痛患者时,因阿片类药物治疗疼痛直接导致的强迫性觅药和成瘾现象就更为明显。尽管目前现有的流行病学证据基础尚不完善,但在接受阿片类药物治疗的慢性疼痛患者中,似乎有一部分人存在阿片类药物使用问题,而且这些问题行为和成瘾是需要解决的问题。由于成瘾可能带来的毁灭性影响会大大抵消阿片类药物缓解疼痛的益处,因此重新审视成瘾机制及其与长期阿片类药物疼痛治疗实践的相关性似乎很有必要。本文综述了成瘾的神经生物学和遗传学基础、其术语和诊断、阿片类药物治疗慢性疼痛期间的成瘾率证据,以及生物学机制在制定合理阿片类药物治疗方案中的意义。